2024-512792-13-00CompletedPhase 1
Evaluation of the CHF 5993 concentration in blood, after inhalation with two different devices, (NEXThaler® versus pMDI), with and without Aerochamber spacer device, in healthy volunteers.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 21 Oct 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 66 (actual)
- First submitted
- 23 Aug 2024
- Start date
- 13 Nov 2024
- Lead sponsor
- Chiesi Farmaceutici S.p.A.
- Diseases
- Asthma
- EU CT number
- 2024-512792-13-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 66
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| SGS Belgium | Edegem | Belgium | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.